The use of vasopressor agents in shock is of established value and has become a common form of treatment. Aramine was used in over 250 unselected cases of shock of varied etiology, of which 42 cases are reported in some detail. This agent continues to produce a vasopressor effect after the actual cessation of administration, and its use is characterized by ease in maintaining the desired blood pressure level. Distressing side effects, such as thrombophlebitis or tissue slough, do not occur.
T"'~H E use of Aramine, a sympathomimetic amine, in normal subjects was reported in 1954.1 This study indicated the effectiveness of this drug as a vasopressor and suggested certain advantages over other commonly used vasopressors. Therefore, an extended study of the effects of Aramine in clinical shock states was undertaken, and the results are herewith reported.
METHOD
Every case admitted to the First Division Medical Service, Kings County Hospital Center, in which the use of a vasopressor was indicated received Aramine.* In each case the drug was administered intravenously diluted in 1000 ml. of 5 per cent dextrose in water. Early in the study, 50 mg. of Aramine was diluted in 1000 ml. of 5 per cent dextrose in water. The infusion was initiated at a rate of 80 to 100 drops per minute, and then regulated according to the blood pressure response. If the response was inadequate after 10 minutes, another 25 mg. of Aramine was added to the infusion. By this method, it was soon found that a higher concentration of Aramine was both safe and preferable. Three hundred milligrams of Aramine per 1000 ml. of dextrose in water soon became the concentration of choice. The blood pressure was recorded every minute, for the first 5 to 10 minutes, then every 5 minutes until the blood pressure was maintained at the desired level, and finally recordings were made as indicated by the severity of the case and duration of treatment. In those cases in which the blood pressure did not respond quickly, norepinephrine was substituted. 
stituting a vasopressor for blood or fluid replacement, for example. In cases of hemorrhage in this study, Aramine in infusions was used only until matched blood was available.
Particular mention is given the use of Aramine in shock due to myocardial infarction, solely because of the current interest in the use of vasopressors in this condition. No blanket endorsement for the use of Aramine, or any other vasopressor, in shock due to myocardial infarction is intended.
With 300 mg. per 1000 ml. of 5 per cent dextrose in water, a rise in blood pressure to adequate levels can be anticipated within 5 minutes. Lack of response within 10 minutes usually indicated complete failure of vasopressor therapy. In many instances, therapy with Aramine was maintained for long periods of time (24 days in one case). In all cases it was noted that after discontinuing Aramine, the blood pressure gradually fell to levels that caused some alarm to the resident staff and it seemed advisable to restart Aramine immediately. In most instances, however, it was found that reinstitution of therapy was unnecessary, for the patients' blood pressures gradually readjusted to withdrawal of the pressor agent over a period of hours.
Advantages of Aramine over other pressor agents compared in the pilot study' were verified in the present study and several new advantages were noted. Relative ease of control of blood pressure levels was again noted; the blood pressure rose rapidly to the desired level, without the meteoric rise to excessive levels so often encountered with other agents. When Aramine was stopped, intentionally or otherwise, the fall in pressure was a gradual one over a period of 10 to 15 minutes, as contrasted with the precipitous drop in pressure often seen on withdrawal of other pressor amines. This characteristic is of particular advantage in cases where extended therapy is necessary and eventual dislodging of the needle from the vein is a practical certainty. The continued pressor effect allows adequate time for reinserting the needle in a new vein.
In no instance was there any deleterious result from infiltration of the tissues by infusion fluid containing Aramine. In fact, unintentional intramuscular administration of undiluted Aramine in two instances caused no untoward effects. In using another potent pressor agent at this hospital, threading a polyethylene tube through the infusion needle into the vein for several inches has become common practice in an attempt to prevent thrombophlebitis or distressing tissue sloughs. No such precaution is necessary in using Aramine; neither slough nor thrombophlebitis was noted in any of the cases studied.
SUMMARY
Experiences with the use of Aramine in clinical shock of varied etiology in over 250 cases is described. Aramine possesses advrantages that make it a safe and useful agent in conditions where a potent v asopressor drug is indicated. SUMMARIO 
